purpos
studi
compar
sampl
efficaci
rayon
swab
nylon
flock
swab
oropharyng
nasopharyng
specimen
detect
respiratori
virus
elderli
patient
sampl
obtain
patient
year
age
newli
admit
sorlandet
hospit
arend
norway
patient
interview
current
symptom
respiratori
tract
infect
use
rayon
swab
nylon
flock
swab
compar
set
mucos
sampl
harvest
nasopharynx
oropharynx
sampl
analys
use
realtim
polymeras
chain
reaction
pcr
method
total
patient
mean
age
year
standard
deviat
sd
year
swab
viru
recov
symptomat
patient
regardless
sampl
site
calcul
time
higher
viral
load
confid
interv
ci
obtain
use
nylon
flock
swab
compar
rayon
swab
also
regardless
type
swab
calcul
time
higher
viral
load
found
sampl
nasopharynx
compar
oropharynx
ci
p
swab
respiratori
virus
elderli
patient
nasopharyng
rather
oropharyng
sampl
obtain
nylon
flock
swab
appear
effici
rayon
swab
recent
year
respiratori
virus
establish
signific
caus
mortal
morbid
older
popul
howev
respiratori
pathogen
may
caus
similar
clinic
pictur
aetiolog
diagnosi
depend
laboratori
confirm
demonstr
respiratori
syncyti
viru
rsv
viral
detect
demand
elderli
young
individu
older
peopl
tend
shed
less
viru
shorter
viralshed
period
henc
rapid
viral
antigen
test
use
children
may
fail
elderli
due
high
sensit
specif
realtim
polymeras
chain
reaction
pcr
respiratori
viral
sampl
repres
import
diagnost
opportun
also
older
age
group
sampl
diagnosi
respiratori
viral
infect
obtain
swab
oropharynx
nasal
caviti
nasopharynx
altern
nasopharyng
aspir
npa
nasopharyng
wash
npw
care
conduct
npa
npw
usual
provid
suffici
diagnost
materi
children
young
adult
howev
frail
elderli
npa
npw
less
well
toler
reason
nasopharyng
swab
np
prefer
sampl
method
older
adult
although
slightli
fewer
epitheli
cell
recov
np
compar
npa
npw
two
structur
differ
swab
avail
microbi
sampl
upper
airway
rayon
swab
nylon
flock
swab
studi
compar
respect
efficaci
two
swab
provid
diagnost
specimen
perform
children
knowledg
studi
conduct
elderli
aim
studi
compar
respect
efficaci
rayon
swab
nylon
flock
swab
provid
materi
direct
respiratori
viru
detect
realtim
pcr
adult
year
age
also
compar
diagnost
yield
sampl
recov
oropharynx
nasopharynx
studi
design
approv
norwegian
region
committe
research
ethic
studi
took
place
februari
februari
depart
intern
medicin
sorlandet
hospit
arend
norway
twice
week
patient
born
earlier
admit
hospit
previou
day
interview
two
team
member
symptom
describ
tabl
first
last
four
week
studi
patient
ask
take
part
regardless
symptom
wherea
rest
studi
period
patient
symptom
ask
particip
patient
unabl
suppli
inform
need
next
kin
andor
concern
hospit
staff
interview
patient
abl
give
inform
consent
next
kin
ask
permiss
rayon
swab
virocult
swab
virocult
medic
wire
equip
corsham
uk
use
oropharynx
nasopharynx
respect
rayon
swab
insert
virocult
medium
immedi
sampl
tip
tube
squeez
instruct
manufactur
nylon
flock
swab
nylon
flock
swab
regular
nasopharyng
copan
italia
brescia
itali
use
oropharynx
nasopharynx
respect
nylon
flock
swab
insert
univers
transport
medium
utm
tube
ml
medium
bead
copan
italia
tube
shaken
swab
oropharynx
sampl
taken
tonsil
posterior
oropharyng
area
nylon
flock
swab
use
one
side
rayon
swab
tongu
depressor
use
procedur
care
taken
avoid
touch
tongu
swab
swab
nasopharynx
swab
insert
nostril
push
back
far
possibl
rotat
withdrawn
nylon
flock
swab
use
one
nostril
rayon
swab
swab
conduct
two
experienc
team
member
patient
underw
mucosa
swab
oropharynx
nasopharynx
day
admitt
inclus
criteria
patient
born
earlier
least
one
follow
current
symptom
debut
less
three
week
ago
nasal
congest
runni
nose
throat
pain
fever
malais
muscl
pain
selfdiagnosi
common
cold
diarrhoea
eye
infect
combin
laboratori
valu
support
infect
tabl
inclus
criteria
hospit
four
week
patient
test
posit
respiratori
viru
retest
oropharyng
nasopharyng
swab
swab
perform
follow
order
right
oropharyng
area
left
oropharyng
area
left
nasopharynx
right
nasopharynx
order
two
type
swab
use
decid
block
randomis
one
swab
use
per
transport
tube
regardless
type
swab
locat
swab
tube
store
room
temperatur
transport
microbiolog
laboratori
within
h
specimen
kept
room
temperatur
nucleic
acid
extract
usual
took
place
within
h
alway
within
h
pcr
analys
perform
within
next
h
els
nucleic
acid
eluat
store
test
use
monoplex
rsv
human
metapneumoviru
multiplex
influenza
ab
adenovirusintern
control
parainfluenza
viru
pcr
method
specimen
examin
total
nine
differ
respiratori
virus
tabl
achiev
complet
diagnost
coverag
respiratori
pathogen
pcr
assay
ad
detect
mycoplasma
pneumonia
chlamydophila
pneumonia
bordetella
pertussi
extract
total
nucleic
acid
rayon
swab
incub
min
trisedta
te
buffer
thorough
stir
sampl
subject
nucleic
acid
extract
magnapur
lc
instrument
roch
diagnost
mannheim
germani
use
magna
total
nucleic
acid
isol
kit
roch
ca
sampl
elut
buffer
abl
detect
inhibit
pcr
assay
specimenspecif
inhibitor
final
concentr
phage
dna
copiesml
tib
molbiol
cat
ad
te
buffer
done
flock
swab
control
sampl
phage
dna
includ
extract
run
order
ensur
neg
result
due
poor
process
cdna
synthesi
cdna
synthesi
perform
qscript
cdna
synthesi
kit
quanta
bioscienc
gaithersburg
md
usa
cat
follow
manufactur
protocol
reaction
incub
min
min
inactiv
min
cdna
sampl
subject
amplif
immedi
realtim
pcr
assay
adenoviru
realtim
pcr
assay
perform
use
kit
tib
molbiol
cat
accord
manufactur
protocol
realtim
pcr
perform
use
c
dna
reaction
mixtur
consist
mm
mgcl
unit
uracildna
glycosylas
eurogentec
sera
belgium
lightcycl
faststart
dna
master
mix
roch
cat
primer
probe
primer
probe
list
tabl
pcr
cycl
condit
initi
min
follow
min
cycl
pcr
amplif
amount
dna
doubl
cycl
compon
reaction
reach
critic
level
exponenti
relationship
initi
amount
templat
dna
cycl
threshold
ct
valu
high
ct
valu
repres
low
microbi
load
specimen
sampl
differ
factor
two
origin
dna
concentr
would
expect
one
cycl
apart
run
wherea
sampl
differ
factor
ten
would
approxim
cycl
apart
differ
ct
valu
obtain
experiment
run
demonstr
rel
differ
concentr
sampl
use
calcul
differ
viral
load
amplif
effici
pcr
assay
use
studi
measur
descript
statist
use
describ
popul
linear
mix
model
appli
data
compar
two
type
swab
origin
sampl
random
effect
patient
statist
analysi
base
ct
valu
ct
valu
design
cutoff
valu
posit
result
thu
lower
ct
valu
sampl
correspond
higher
microbi
load
sampl
ct
valu
analys
continu
data
statist
analys
perform
use
spss
spss
inc
chicago
il
usa
total
patient
interview
current
symptom
respiratori
tract
infect
tabl
patient
report
least
one
symptom
agre
test
accord
studi
protocol
twentysix
patient
refus
particip
male
femal
mean
age
year
standard
deviat
sd
year
first
last
four
week
studi
patient
without
symptom
agre
swab
well
altogeth
patient
male
femal
mean
age
year
sd
year
swab
swab
use
total
patient
swab
four
swab
patient
three
five
patient
two
one
patient
one
swab
viru
recov
least
one
swab
symptomat
patient
tabl
report
symptom
respiratori
tract
infect
patient
test
posit
one
viru
viru
found
reswab
previous
posit
patient
four
week
one
patient
test
posit
bordetella
pertussi
none
chlamydophila
pneumonia
mycoplasma
pneumonia
bacteri
infect
focu
current
studi
result
exclud
follow
analysi
gener
nasopharyng
swab
posit
lower
ct
valu
compar
oropharyng
swab
mean
differ
ct
ci
p
regardless
sampl
type
fig
calcul
viral
load
time
higher
ci
oropharynx
influenza
virusposit
sampl
show
lower
ct
valu
nasopharynx
oropharynx
mean
differ
ct
valu
ci
p
repres
calcul
time
higher
ci
viral
load
nasopharynx
knowledg
comparison
nylon
flock
swab
rayon
swab
conduct
elderli
popul
present
studi
favour
nasopharyng
sampl
nylon
flock
swab
calcul
time
higher
viral
dna
concentr
found
nylon
flock
swab
regardless
sampl
origin
nylon
flock
swab
seem
adher
epitheli
cell
rayon
swab
might
least
part
explain
lower
ct
valu
obtain
use
flock
swab
nasopharyng
aspir
consid
gold
standard
materi
diagnosi
respiratori
virus
children
sensit
level
slightli
nasopharyng
nylon
flock
swab
comparison
nylon
flock
swab
nasopharyng
aspir
elderli
popul
publish
term
ct
found
nasopharyng
sampl
superior
oropharyng
sampl
yield
calcul
time
higher
concentr
viral
nucleic
acid
correspond
result
found
studi
lieberman
et
al
much
broader
variat
patient
age
subgroup
analysi
influenza
viru
reveal
calcul
time
higher
viral
load
sampl
nasopharynx
shown
tabl
sever
sampl
neg
influenza
viru
oropharynx
posit
nasopharynx
nasopharyng
swab
easi
use
proper
instruct
swab
microbiolog
agent
often
left
least
train
medic
staff
case
suboptim
swab
may
rel
common
sampl
collect
studi
perform
two
experienc
team
member
thu
minimis
risk
suboptim
sampl
wherea
usual
consider
effort
made
optimis
diagnost
procedur
laboratori
less
emphasi
tend
place
preced
procedur
sampl
collect
believ
lot
gain
increas
awar
proper
sampl
techniqu
sampl
tool
semiquantit
assess
respiratori
pathogen
children
immunofluoresc
assay
viral
cultur
wide
appli
wherea
current
studi
ct
valu
obtain
purpos
studi
appli
realtim
pcr
detect
respiratori
agent
simpli
determin
whether
infect
howev
within
pcr
experi
close
relationship
achiev
ct
valu
initi
amount
specif
nucleic
acid
sampl
studi
sampl
taken
time
patient
compar
ct
valu
use
calcul
collect
experi
calcul
differ
viral
load
reli
upon
use
pcr
assay
high
amplif
effici
factor
one
examin
minimis
manner
method
provid
valid
rel
quantit
data
compar
distinct
sampl
materi
found
respiratori
virus
studi
popul
correspond
number
report
author
rang
depend
virus
includ
pcr
analysi
chose
includ
microbi
agent
respons
signific
ill
thu
exclud
frequent
occur
caus
upper
respiratori
tract
infect
rhinoviru
coronaviru
number
patient
diagnos
influenza
rsv
infect
lower
studi
report
other
probabl
due
annual
variat
find
respiratori
virus
nonsymptomat
patient
two
period
patient
regardless
symptom
swab
respiratori
virus
found
patient
total
studi
popul
author
conclud
combin
oropharyng
sampl
nasopharyng
sampl
npa
repres
ideal
sampl
method
diagnosi
respiratori
tract
virus
howev
busi
clinic
set
may
hard
enough
ensur
one
properli
collect
sampl
concern
patient
conclus
respiratori
tract
infect
requir
aetiolog
clarif
ration
approach
virolog
part
investig
obtain
nasopharyng
sampl
prefer
collect
train
personnel
least
cost
compar
use
nylon
flock
swab
rather
rayon
swab
